Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study | Synapse

⌘+K

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challengesHuman Clinical Trial · 2019 · 125 citations
2Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyEarly-Phase Clinical Trial · 2017 · 440 citations
3Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapyOriginal Research · 2018 · 222 citations
4Current and future management of Ph/BCR-ABL positive ALLOriginal Research · 2014 · 46 citations
5Current Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaOriginal Research · 2011 · 53 citations

More from European Journal of Cancer

More from Cornell University